These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 22085470)

  • 1. To evaluate the effect of addition of an anionic surfactant on solid dispersion using model drug indomethacin.
    Dave RH; Patel AD; Donahue E; Patel HH
    Drug Dev Ind Pharm; 2012 Aug; 38(8):930-9. PubMed ID: 22085470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. To evaluate the change in release from solid dispersion using sodium lauryl sulfate and model drug sulfathiazole.
    Dave RH; Patel HH; Donahue E; Patel AD
    Drug Dev Ind Pharm; 2013 Oct; 39(10):1562-72. PubMed ID: 23030270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation, characterization and tableting of cilnidipine solid dispersions.
    Hu L; Song W; Niu F; Jiao K; Jia Z
    Pak J Pharm Sci; 2013 May; 26(3):629-36. PubMed ID: 23625441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New metastable form of glibenclamide prepared by redispersion from ternary solid dispersions containing polyvinylpyrrolidone-K30 and sodium lauryl sulfate.
    Thongnopkoon T; Puttipipatkhachorn S
    Drug Dev Ind Pharm; 2016 Jan; 42(1):70-79. PubMed ID: 25835067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Polymer/Surfactant as Carriers on the Solubility and Dissolution of Fenofibrate Solid Dispersion.
    Yang B; Wu L; Ke J; Zhou L; Chen M; Li S; Feng X
    AAPS PharmSciTech; 2019 Feb; 20(3):102. PubMed ID: 30723877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: selection of polymer-surfactant combinations using solubility parameters and testing the processability.
    Ghebremeskel AN; Vemavarapu C; Lodaya M
    Int J Pharm; 2007 Jan; 328(2):119-29. PubMed ID: 16968659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. QbD approach of rapid disintegrating tablets incorporating indomethacin solid dispersion.
    Sammour OA; Hammad MA; Zidan AS; Mowafy AG
    Pharm Dev Technol; 2011 Jun; 16(3):219-27. PubMed ID: 20163325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of SLS: APG mixed surfactant systems as carrier for solid dispersion.
    Patel AR; Joshi VY
    AAPS PharmSciTech; 2008; 9(2):583-90. PubMed ID: 18459049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel valsartan-loaded solid dispersion with enhanced bioavailability and no crystalline changes.
    Yan YD; Sung JH; Kim KK; Kim DW; Kim JO; Lee BJ; Yong CS; Choi HG
    Int J Pharm; 2012 Jan; 422(1-2):202-10. PubMed ID: 22085435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism for the Reduced Dissolution of Ritonavir Tablets by Sodium Lauryl Sulfate.
    Guo Y; Wang C; Dun J; Du L; Hawley M; Sun CC
    J Pharm Sci; 2019 Jan; 108(1):516-524. PubMed ID: 30389564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of dissolution profile by solid dispersion (kneading) technique.
    Modi A; Tayade P
    AAPS PharmSciTech; 2006 Aug; 7(3):68. PubMed ID: 17025249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fusion Method for Solubility and Dissolution Rate Enhancement of Ibuprofen Using Block Copolymer Poloxamer 407.
    Dugar RP; Gajera BY; Dave RH
    AAPS PharmSciTech; 2016 Dec; 17(6):1428-1440. PubMed ID: 26817763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of sodium dodecyl sulphate on the dissolution of poorly soluble drug into biorelevant medium from drug-surfactant discs.
    Madelung P; Ostergaard J; Bertelsen P; Jørgensen EV; Jacobsen J; Müllertz A
    Int J Pharm; 2014 Jun; 467(1-2):1-8. PubMed ID: 24594297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Raman and thermal analysis of indomethacin/PVP solid dispersion enteric microparticles.
    Fini A; Cavallari C; Ospitali F
    Eur J Pharm Biopharm; 2008 Sep; 70(1):409-20. PubMed ID: 18621516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solid molecular dispersions of poorly water-soluble drugs in poly(2-hydroxyethyl methacrylate) hydrogels.
    Zahedi P; Lee PI
    Eur J Pharm Biopharm; 2007 Mar; 65(3):320-8. PubMed ID: 17182231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of drug-carrier interaction on the dissolution behavior of solid dispersion tablets.
    Srinarong P; Kouwen S; Visser MR; Hinrichs WL; Frijlink HW
    Pharm Dev Technol; 2010; 15(5):460-8. PubMed ID: 20735300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of an oral solid dispersion formulation for use in low-dose metronomic chemotherapy of paclitaxel.
    Moes J; Koolen S; Huitema A; Schellens J; Beijnen J; Nuijen B
    Eur J Pharm Biopharm; 2013 Jan; 83(1):87-94. PubMed ID: 23085332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solubilization and formulation of chrysosplenol C in solid dispersion with hydrophilic carriers.
    Ng CL; Lee SE; Lee JK; Kim TH; Jang WS; Choi JS; Kim YH; Kim JK; Park JS
    Int J Pharm; 2016 Oct; 512(1):314-321. PubMed ID: 27593897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation optimization of solid dispersion of mosapride hydrochloride.
    Kim HJ; Lee SH; Lim EA; Kim JS
    Arch Pharm Res; 2011 Sep; 34(9):1467-75. PubMed ID: 21975808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-destructive methods of characterization of risperidone solid lipid nanoparticles.
    Rahman Z; Zidan AS; Khan MA
    Eur J Pharm Biopharm; 2010 Sep; 76(1):127-37. PubMed ID: 20470882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.